United States: Medicare Advantage And Small Business Insurance Market Reforms

In Depth

The 21st Century Cures Act includes provisions affecting Medicare Advantage, drawing from the bipartisan Senate Finance Committee's Chronic Care Working Group, and the small employer health insurance market. These provisions are primarily contained in titles XVII and XVIII of the new legislation.

The law includes the following changes, among several others affecting Medicare Advantage, Part D and insurance for small employers:

  • Allowing Medicare beneficiaries with end-stage renal disease (ESRD) to enroll in Medicare Advantage plans beginning in 2021
  • Requiring changes to the risk adjustment methodology, beginning in 2019
  • Postponing the Centers for Medicare & Medicaid Services' (CMS's) ability to terminate contracts with Medicare Advantage Organizations that do not achieve Star Ratings of at least three Stars for successive years until plan year 2019

Expanding Medicare Advantage to Include End-Stage Renal Disease Beneficiaries (§ 17006)

Starting 2021, all Medicare beneficiaries suffering from ESRD will have the option to enroll in a Medicare Advantage plan. Coverage for kidney transplants will be carved out of the Medicare Advantage plan and reimbursed under Parts A and B. In light of this change, the secretary of the US Department of Health and Human Services (HHS) must consider (1) incorporating into the Star Rating system a quality measure specific to ESRD coverage and (2) revising the Medicare Advantage risk adjustment model to include additional factors regarding chronic kidney disease.

Providing ESRD patients with expanded access to Medicare Advantage coverage could dramatically reshape treatment of and payment for the treatment of Medicare beneficiaries with chronic kidney disease. The Medicare Payment Advisory Commission endorsed opening Medicare Advantage to ESRD patients in 2000. More recently, the bipartisan Senate Finance Committee's Chronic Care Working Group promoted this policy in its draft legislation. Prominent patient and industry groups including the America's Health Insurance Plans and the National Kidney Foundation endorsed this effort to open access to Medicare Advantage to ESRD patients. Other stakeholders expressed concern that risk adjustment payments for ESRD patients may be inadequate to cover the cost of dialysis treatment.

These changes are a number of years away, but in preparation:

  • Plans should consider how including the ESRD population in the risk pool will affect rate development and their existing provider agreements.
  • Plans should evaluate other key factors that could be incorporated into the risk adjustment model to best represent the risk of covering ESRD beneficiaries.
  • Plans should monitor CMS for requests for information, rulemaking and other guidance regarding updates to the Medicare Advantage risk adjustment model.
  • Providers should evaluate their current membership in Medicare Advantage plan networks and the capacity and volume assumptions underlying their participation agreements.

Modifying the Medicare Advantage Risk Adjustment Model Beginning in 2019 (§ 17006)

The Act also directs numerous changes to the Medicare Advantage risk adjustment model beginning in 2019. Under the legislation, the model must take into account the total number of diseases or conditions of a Medicare Advantage enrollee. Additionally, CMS would be able to use two years of diagnosis data when determining beneficiary health conditions. The model must also separately adjust for "fullbenefit" and other dual-eligibles. Finally, the secretary of HHS must evaluate the inclusion of additional factors, including mental health and substance abuse, into the model. These changes to the risk adjustment model will impact all Medicare Advantage plans. The changes are intended to result in more favorable treatment for plans with patients who have chronic conditions. The modifications to the risk adjustment model were previously included in the Senate Finance Committee's Chronic Care Working Group draft legislation, and a number of patient and industry groups have endorsed the effort.

CMS has recently modified the risk adjustment model to account for the risk of enrolling different groups of beneficiaries (e.g., "fullbenefit" dual-eligible beneficiaries). In 2016, CMS announced that the 2017 risk adjustment model would be separated into six subgroups based on dual eligibility status.

In preparation for the changes:

  • Plans should consider how a modified risk adjustment model will impact rate development and existing capitated provider agreements.
  • Plans should evaluate other key factors that could be incorporated into the risk adjustment model to best represent the risk of covering beneficiaries with chronic conditions. Plans should monitor CMS for requests for information, rulemaking and other guidance regarding updates to the Medicare Advantage risk adjustment model. Traditionally, CMS issues changes and proposed changes through the Advance Notice and Final Rate Announcement process, which for plan year 2019, is expected to kick off in February 2018. However, CMS will likely begin the process of considering adjustments to the model before then.

Star Rating Exclusion Delay (§ 17001)

Another section of the Act suspends CMS's authority to terminate a Medicare Advantage plan solely on the basis of the plan's performance in the Star Ratings system through the end of plan year 2018. CMS has in the past voluntarily chosen not to exercise its termination authority, but announced in the 2016 and 2017 Call Letters that it would begin doing so, and issued at least one non-renewal notice in 2016 that will be effective December 31, 2016.

The Star Ratings system is central to CMS's goal of improving the quality of services provided to Medicare beneficiaries. Star Ratings help beneficiaries compare plan quality and determine plan bonus payments. CMS currently has the authority to terminate Medicate Advantage plans for failure to achieve a rating of at least three Stars in at least one out of three consecutive years.

Because the Act also requires CMS to continue to study the impact of socioeconomic status on Star Ratings, this suspension appears to stem from concerns that the Star Ratings system unfairly penalizes plans that enroll disproportionate numbers of low-income and disabled beneficiaries. In 2015, CMS engaged RAND Corporation to study this issue and concluded that there was some evidence of within-contract disparities between lowincome/ disabled members and other members at least for a subset of the Star Ratings measures. The size of the effect differed across measures and was not exclusively negative. In an effort to address these within-contract disparities, CMS implemented an adjustment factor for the 2017 Star Ratings based on each contract's low-income subsidy, dual-eligible and disabled enrollment.

CMS began exercising its authority under the Affordable Care Act (ACA) to non-renew contracts with consistently low Star Ratings in 2016, but the impact of this termination authority is limited in scope. Only a handful of contracts each year have fallen into the band where termination is possible, and some of these companies have higher-performing contracts into which the lowperforming contracts could be consolidated. The suspension of this termination authority in the 21st Century Cures Act provides short-term relief for a small number of contracts that may otherwise have received non-renewal notices in February 2017 (effective December 31, 2017).

Implications and action steps for plans are as follows:

  • This delay offers a temporary reprieve to a handful of Medicare Advantage plans at risk of termination. Lowerranked plans forego significant bonus opportunities and tend to grow at slower rates than plans with higher Star Ratings.
  • Plan Sponsors that may have been considering consolidating low-performing contracts into higher performing contracts may now abandon or delay any changes.
  • The ongoing work on socioeconomic status and dualeligible status could provide plans an opportunity to engage with CMS and shape the more permanent adjustment.

Requirement to Update Medicare Enrollment Handbook (§ 17003)

The Act also requires the secretary of HHS to update the "Welcome to Medicare" package to include information about the options for receiving benefits under Medicare Parts A through D, after consulting with stakeholders.

The Welcome to Medicare package is often the first document newly eligible beneficiaries receive, and is a key opportunity for beneficiaries to learn about enrollment in Medicare and their option to enroll in Parts C and D. Enrollment errors often result in coverage delays and lifetime premium penalties. Beneficiary advocacy groups believe that updating the package will reduce such errors.

Updates to the package may offer Medicare Advantage plans the opportunity to influence how beneficiaries are first introduced to the Medicare Program and to shape their view of Medicare Advantage in relation to Parts A and B. With a new administration handling development of the package, additional emphasis on Parts C and D in the handbook may drive increased enrollment in those programs.

Medicare Advantage plans should monitor CMS for requests for information or comment regarding updating the package and should consider responding to CMS with advice leveraging their expertise in outreach to and education of beneficiaries.

Restoring the Medicare Advantage Open Enrollment Period (§ 17005)

Another provision of the Act implements changes to Medicare Advantage open enrollment. Currently, a beneficiary enrolled in a Medicare Advantage plan may elect to disenroll from her plan and enroll in Medicare Parts A and B within the first 45 days of a year or, for a newly eligible beneficiary who has enrolled in a Medicare Advantage plan, in the first 45 days of coverage. Changes to other Medicare Advantage plans during this time period are not allowed under current law.

The Act restores a Medicare Advantage open enrollment period similar to the open enrollment period that existed prior to the enactment of the ACA, representing in part a rolling back of one of the ACA's less popular provisions. Under the Act, beginning in 2019, a Medicare Advantage or Part D enrollee will be able to elect to change her enrollment to either another Medicare Advantage Plan or to Medicare Parts A and B within the first three months of the year or, for a newly eligible beneficiary who has enrolled in a Medicare Advantage plan, the first three months of her coverage. One important distinction between this provision and the open enrollment period as it existed prior to the ACA is that this provision does not restrict changing enrollment between Medicare Advantage plans that include drug coverage and those that do not.

The change to open enrollment gives plans an additional three-month opportunity to enroll beneficiaries, but may also introduce administrative complexities associated with mid-year transitions between plans. In preparation for the changes:

  • Plans should consider adjusting their enrollment and termination policies for 2019 to accommodate this new enrollment period.
  • Plans should monitor for CMS guidance implementing this provision and update their marketing practices for 2019 to align with permissible marketing practices for newly enrolled Medicare Advantage beneficiaries.

Qualified Small Employer HRAs (§ 18001)

The Act also authorizes small employers to make taxadvantaged contributions through individual Health Reimbursement Accounts (Individual HRAs) towards the purchase of individual health insurance coverage by their employees. Currently, such contributions conflict with ACA minimum coverage standards and are penalized under the tax code. The adoption of this policy may represent an acknowledgement that small businesses have not fared well under the ACA, as fewer offer coverage today than prior to the law's enactment.

Individual HRAs represent both a challenge and opportunity for health insurance issuers. The shift of a significant portion of current small group enrollment to the individual market would potentially introduce uncertainty into small group rate setting and expected risk adjustment outcomes. Conversely, such a shift in enrollment to the individual market may assist in stabilizing the current uncertainty in that market. Because small businesses may begin shifting their coverage to the individual market starting in 2017, issuers will have limited opportunities to adapt to this new reality.

Individual HRAs present an opportunity for small businesses to simplify the administration of their health benefits. However, because in most states individual market premiums vary by age and because the Act permits variation in employer contributions based on premiums, small employers should ensure their contributions towards Individual HRAs are structured consistent with applicable federal law including the Age Discrimination in Employment Act (ADEA).

In preparation for this change:

  • Issuers should take advantage of all mid-year ratesetting opportunities to adjust rates to align with expected changes in enrollment.
  • Issuers should prepare for potential changes to enrollment in their small group plans.
  • Issuers should prepare for a potential influx of new members (potentially with lower overall health risks) into their individual market plans.
  • Employers wishing to offer Individual HRAs to their employees should consider applicable state and federal employment laws, including the ADEA, when structuring Individual HRA employee contributions.

Seth Schneer, an associate in the Washington, DC, office, also contributed to this article.

Medicare Advantage And Small Business Insurance Market Reforms

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
Drinker Biddle & Reath LLP
Drinker Biddle & Reath LLP
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Drinker Biddle & Reath LLP
Drinker Biddle & Reath LLP
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions